B. Metzler Seel. Sohn & Co. Ag Insmed Inc Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Insmed Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 10,510 shares of INSM stock, worth $855,093. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,510
Previous 10,510
-0.0%
Holding current value
$855,093
Previous $767,000
5.48%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding INSM
# of Institutions
496Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.16 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.05 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$1.03 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$579 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $11B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...